Name | Rulonilimab |
---|
Description | Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |